David Springer is a serial entrepreneur leader with more than 35 years of experience in healthcare with focus in the medical device and digital health industries. He serves on several boards and most recently was President and Chief Executive Officer, Verve Medical, an early-stage company with a device to treat hypertension. Previously, Springer held the position of COO at Sharecare, where he guided them to profitability and significant growth of this now public company in Digital Health & Wellness. Prior to this he led two commercial stage companies to growth and a strategic exit.  As President and CEO, Cayenne Medical, the team development and expanded into the shoulder market which helped achieve 35% growth and the ultimate acquisition by Zimmer Biomet. Post acquisition, Springer assumed the GM of the Orthopedic Sports Medicine, a $350million division of Zimmer. He also led CHF Solutions as President and CEO where among his many achievements was a successful acquisition of the company by Gambro. Prior to this, Springer held the position of Sr. Vice President for St. Jude Medical where he was instrumental in creating and leading all US strategic and operational plans. In 1997, he was a member of the founding management team of WebMD (formerly QDCS, Inc.) where he held the positions of Executive Vice President of Business Development and Senior Vice President of Sales. Prior to WebMD, Springer served in various leadership positions in sales, corporate accounts and marketing at Intermedics, Kimberly Clark Healthcare and Procter & Gamble. Springer received his Bachelor of Science in Industrial Management from Purdue University.

William is an experienced medical device executive specializing in medical design and business development. Cimino has over 25 years of professional experience in all aspects of medical device business, including device design and technology development, clinical studies and assessment, regulatory affairs, strategic market development, distribution, business management and growth, and funding. He has been directly responsible for the design and market introduction of over 50 medical products and has formed and run successful medical device startup companies. Dr. Cimino has been issued over 30 US patents and holds and PhD in Bioengineering, an MS in Mechanical Engineering, and a BS in Aerospace Engineering

Hands-on regulatory professional and engineer with 19 years of experience developing novel Class II and Class III medical devices. Passionate about improving patient outcomes with safe, effective technologies that meet clinical, regulatory, and business needs. Proven track record across FDA PMA, De Novo, 510(k), IDE, Breakthrough Device, and TAP programs for first-of-kind implantable and software-enabled systems in cardiac, vascular, neurosurgical, gastrointestinal, and orthopedic applications. Expert in embedding regulatory strategy into design controls and pre-clinical/clinical evidence development early within cross-functional teams to reduce rework, control risk, accelerate time to market, and build scalable platforms aligned with financing and long-term value creation goals.

Matt has 19+ years of broad medical device experience in R&D, manufacturing, and business development, where he has a track record of product launches in the vascular and orthopedic markets. His experience includes stints at start-ups such as Cayenne Medical, Verve Medical, and Anuncia Medical, as well as large companies like Bard Peripheral Vascular and BD. Matt has submitted 32 patent applications as an inventor. Matt received his undergraduate Bioengineering and MBA degrees from Arizona State University.

Dwight Zurawski, CPA, joined GID Bio as Chief Financial Officer in August 2023.  He has been providing public accounting services for the Company since 2012.  He oversees the company’s financial operations and information technology.  He has extensive financial leadership experience in the medical device manufacturing industry, combining technical expertise with strategic business insight.   

Dwight began his career in public accounting with KPMG – Albuquerque as Tax Manager and Audit Senior, gaining experience in taxation, audit, and SEC financial reporting.   His SEC reporting experience includes previous employment with StorageTek and IBM.  He has served 20+ years as CFO / controller for emerging medical equipment manufacturers.  This unique combination of public accounting and private industry experience gives him a broad perspective and practical understanding of issues facing FDA-regulated, technology-driven businesses.

He earned a BBA in Accounting from the University of New Mexico Anderson School of Management.  Dwight holds both CPA and Chartered Global Management Accountant (CGMA) credentials.

Adam Greenhut is a quality systems leader with over 10 years of experience in the medical device industry. He has experience across the product lifecycle, supporting development, clinical, and commercial readiness through compliant and scalable quality systems. His past roles include QMS auditing and consulting at ERI Group, as well as laboratory positions at Medtronic. He earned his bachelor’s in biology from the University of Colorado Denver.

Roy is an investor and businessman who has helped lead numerous global enterprises spanning the fields of advertising, aerospace, manufacturing, technology and finance. Bostock had a long and successful career in the advertising arena, which included engineering a merger to form the seventh largest global agency group, later acquired by Publicis Groupe in Paris. Bostock later was named Chairman of Northwest Airlines following its emergence from bankruptcy and helped architect the merger of Northwest and Delta Airlines, becoming Vice Chairman of Delta. Bostock also served as Chairman of Yahoo! Inc. and as a director of Morgan Stanley. Today, he is Chairman of his investment firm, Sealedge Investments, LLC. He graduated Phi Beta Kappa from Duke University, which he attended on a football scholarship and played both football and baseball while majoring in English literature. He earned an MBA from Harvard University.

J. William received his MD from Duke University, followed by General Surgery Residence at Case-Western Reserve University and Plastic Surgery Residency at Johns Hopkins University. He was a Clinical/Research Oncology Fellow in the Surgery Branch at the National Institutes of Health and is Board Certified in General Surgery and in Plastic and Reconstructive Surgery. He was Professor and Chief of Plastic Surgery at the University of Pittsburgh Medical Center for 21 years, is Past President of the American Association of Plastic Surgeons and multiple other medical organizations and is author or co-author of more than 200 peer-reviewed scientific publications. As an entrepreneur, he is co-inventor of multiple patents and co-founder of numerous businesses including CellSource, Inc.; StemSource, Inc.; Human Analytix, Inc.; Illumineer, Inc.; and Life Science Enhancement Corporation. He is currently Chairman and co-founder of The GID Group, Inc.

Dr. Katz is Professor of Plastic Surgery and Director of the Research Laboratory in the Department of Plastic and Reconstructive Surgery, Wake Forest School of Medicine. He is internationally recognized for his contributions, innovations, and expertise in the science and translation of adipose-derived cell therapies and fat grafting, including the development of device platforms that enable such. In addition to his scientific and entrepreneurial endeavours, he maintains a clinical practice that comprises both reconstructive and aesthetic surgery. He mentors and instructs students and residents at all levels in both the laboratory and clinical setting.

Morgan is the Managing Partner of Wyvern Capital and has been active in merchant banking and investment banking since 1978. He has originated, analyzed, structured, negotiated and syndicated approximately $40 billion of corporate transactions in the US, Europe, Asia, and Latin America. Mr. St. John has successfully assisted and collaborated with numerous investment groups including Manhattan Pacific Partners, Actian Capital, Boyer Capital, Washington Partners Wilson Partners, and Morpheus Capital. Prior to joining Wyvern Capital, Mr. St. John was a Partner and Managing Director at Banker Trust Company, where he built the Los Angeles Finance group and New York Syndication group to become industry leaders in highly structured acquisition financing. Mr. St. John has both his bachelor’s and master’s degrees from Harvard University.

John Marous has led the development of new-start innovative technology businesses since 2002 as CEO of CarrierWeb, LLC (Atlanta, GA, 2003-2011) and CEO and Chairman of CardiacAsisst, Inc. (Pittsburgh, PA 2011-2018). As both businesses have exited to strategic entities, Mr. Marous is now involved in several new technology companies, serving as Chairman of HeartIO, Inc.(Pittsburgh, PA – artificial intelligence in diagnosis of heart disease), Chairman of IACtEx, LLC (Buffalo, NY – manufacturing management systems via internet of things connectivity), director of READA.ai Inc. (Pittsburgh, PA – artificial intelligence to detect stroke in situ during surgery), strategic advisor to Optimus Technologies, Inc. (Pittsburgh, PA – zero emission large trucks/vehicles), and strategic advisor to Heart Repair Technologies, Inc (San Jose, CA – percutaneous mitral valve repair). In the medical device field, he has served as head of R&D, head of Regulatory Affairs, head of Clinical Affairs, in addition to being the complete strategic sales responsibility, with the intent of managing promotion risks related to labeling. He has degrees of BS (in EE) from Cornell University in 1981 and MS from Carnegie Mellon University in 1985.

Nicholas Pachuda is a highly experienced life science executive committed to bringing transformational innovation to the clinic. He possesses deep clinical, technical, and business expertise with both multinationals and startups. He has operational leadership experience as a general manager with commercial P&L responsibility, as well as business development/external innovation and R&D and investment experience as a VC Venture Partner and PE Strategic Advisor. He has served as a startup board member and board advisor.

Dr. Pachuda’s professional experience includes: Peptilogics, Inc, Senior Vice President, Portfolio & Development; Johnson & Johnson, Vice President, External Innovation and Enabling Technologies, DePuy Synthes, Synthes Trauma (a Johnson & Johnson Company), Vice President Marketing and Business Development; Scient’x Spine—with HealthPoint Capital, Vice President Marketing, Professional Education, Clinical Affairs and Compliance; Small Bone Innovations, VP Business Development, Medical Education and Clinical Studies; Arthrex, Product Manager.  He holds a BS in Biology, Chemistry, History and Philosophy of Science from the University of Pittsburgh and a D.P.M. in podiatry from the Pennsylvania College of Podiatric Medicine.